Neil W. Gibson, Chief Scientific Officer at Regulus Therapeutics Inc. (RGLS), sold 80,000 shares at $17.98 ($1.4M) on 2015-01-28, disclosed to the SEC on 2015-01-30.
Scheduled sale ($1.4M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.98 | 71,345 | $1.3M | 88.8% |
| 2 | $18.66 | 8,655 | $162K | 11.2% |
| Total | $18.05 avg | 80,000 | $1.4M | 100% |
| Filing → |
| RGLS | SELL | 2014-10-31 | $48K | — | Filing → |
| RGLS | SELL | 2014-10-24 | $48K | — | Filing → |
| RGLS | SELL | 2014-09-15 | $34K | — | Filing → |